Physician profile
Justin Rocha
NPI 1649942517
$1,140.15
in general payments reported to CMS, 2019-2025
17 companies · $675 in 2025
The $675 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.25 · 2023: $253 · 2024: $201 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,082 · Education: $46.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.35 |
| Education | $46.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $235.98 | 2023-2025 | |
| Lilly USA, LLC | $147.23 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $103.06 | 2021-2025 | Breztri, Airsupra |
| Novo Nordisk INC | $97.94 | 2023-2025 | Ozempic, Rybelsus |
| Phathom Pharmaceuticals, INC. | $90.79 | 2024-2025 | Voquezna |
| Glaxosmithkline, LLC. | $69.59 | 2023-2025 | Trelegy Ellipta |
| Corcept Therapeutics | $68.02 | 2025 | Korlym |
| Amphastar Pharmaceuticals, INC. | $65.65 | 2024-2025 | |
| Exact Sciences Corporation | $59.90 | 2023-2024 | Cologuard Collection Kit |
| Organon LLC | $46.95 | 2023-2025 | Nexplanon |
| E.R. Squibb & Sons, L.L.C. | $46.57 | 2024-2025 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $29.18 | 2023-2025 | |
| Pfizer INC. | $19.11 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.63 | 2025 | Xifaxan |
| Abbott Laboratories | $14.21 | 2025 | Freestyle Libre 3 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $13.85 | 2025 | Slynd |
| Vanda Pharmaceuticals INC. | $13.49 | 2025 | Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Rocha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.